Citigroup Maintains Buy on Medline, Raises Price Target to $47
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Citigroup analyst Joanne Wuensch maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $45 to $47.
Citigroup analyst Joanne Wuensch maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $45 to $47.